OKYO Pharma Limited (NASDAQ:OKYO) Short Interest Update

OKYO Pharma Limited (NASDAQ:OKYO) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 217,900 shares, a drop of 35.5% from the February 28th total of 338,000 shares. Based on an average trading volume of 178,700 shares, the days-to-cover ratio is presently 1.2 days. Currently, 0.9% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and set a $7.00 target price on shares of OKYO Pharma in a research report on Tuesday, February 18th.

OKYO Pharma Price Performance

NASDAQ OKYO traded down $0.08 during mid-day trading on Monday, reaching $1.27. 81,489 shares of the stock were exchanged, compared to its average volume of 192,400. OKYO Pharma has a one year low of $0.81 and a one year high of $1.74. The stock has a 50 day simple moving average of $1.21 and a 200-day simple moving average of $1.12.

About OKYO Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.